Haleon PLC Sponsored ADR (HLN) To Go Ex-Dividend on August 14th

Haleon PLC Sponsored ADR (NYSE:HLN) announced a dividend on Thursday, July 30th. Stockholders of record on Friday, August 14th will be paid a dividend of 0.0642 per share on Thursday, September 17th. This represents a dividend yield of 127.0%. The ex-dividend date is Friday, August 14th.

Haleon has a dividend payout ratio of 46.3% meaning its dividend is sufficiently covered by earnings. Analysts expect Haleon to earn $0.60 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 41.7%.

Haleon Stock Performance

HLN opened at $9.87 on Friday. The stock has a market cap of $43.45 billion, a P/E ratio of 25.29, a P/E/G ratio of 2.34 and a beta of 0.13. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.92 and a quick ratio of 0.71. The stock’s 50 day simple moving average is $9.44 and its 200 day simple moving average is $9.85. Haleon has a 1-year low of $8.65 and a 1-year high of $11.28.

Institutional Investors Weigh In On Haleon

Institutional investors and hedge funds have recently bought and sold shares of the stock. Western Wealth Management LLC purchased a new position in Haleon during the first quarter worth $29,000. Parkside Financial Bank & Trust lifted its position in shares of Haleon by 101.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock valued at $29,000 after acquiring an additional 1,433 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC lifted its position in shares of Haleon by 402.0% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock valued at $30,000 after acquiring an additional 2,404 shares in the last quarter. Geneos Wealth Management Inc. boosted its stake in shares of Haleon by 33.0% during the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after acquiring an additional 1,203 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Haleon by 428.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 6,321 shares of the company’s stock valued at $57,000 after acquiring an additional 5,124 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.